SCHEMBL22849201

SCHEMBL22849201

COc1ccc2c(c1)C(=O)N([C@H]1CC[C@H](CO)CC1)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR2B P41595 2/20 0.47
SCN1A P35498 2/20 0.46
SCN5A Q14524 2/20 0.46
SCN9A Q15858 2/20 0.46
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
MAOA P21397 2/20 0.43
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADAM17 P78536 4/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22836449 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BSCN1ASCN5A
SCHEMBL26352717 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BSCN1ASCN5A
SCHEMBL22835504 0.90 MAOA (0.53) HTR2AHTR2CHTR2BSCN1ASCN5A
SCHEMBL31533425 0.90 HTR2A (0.55) HTR2AHTR2CHTR2BSCN1ASCN5A
SCHEMBL24607464 0.79 SCN1A (0.40) SCN1ASCN5ASCN9AMAOA
SCHEMBL29502309 0.79 SCN1A (0.40) SCN1ASCN5ASCN9AMAOA
Trifluoroacetic Acid SCHEMBL31438769 0.76 HTR2A (0.46) HTR2AHTR2CHTR2BSCN1ASCN5A
SCHEMBL22835245 0.75 SCN1A (0.38) SCN1ASCN5ASCN9AALDH1A1MAOA
SCHEMBL22836453 0.75 SCN1A (0.38) SCN1ASCN5ASCN9AALDH1A1MAOA
SCHEMBL29502492 0.75 SCN1A (0.38) SCN1ASCN5ASCN9AALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed